>

PARABOLIC DRUGS (India) Valuation

<div class='circular--portrait' style='background:#2A0CD0;color: white;font-size:4em;padding-top: 25px;;'>PA</div>
PARABOLIC DRUGS LTD recent Real Value cannot be determined due to lack of data. The prevailing price of PARABOLIC DRUGS LTD is 0.0. Based on Macroaxis valuation methodology, the entity cannot be evaluated at this time. This module determines value of PARABOLIC DRUGS LTD from inspecting the entity fundamentals such as Profit Margin of (78.66) , Price to Sales of 0.05  and Operating Margin of (69.00)  as well as reviewing its technical indicators and Probability Of Bankruptcy. In general, we support investing in undervalued entities and to dispose of overvalued entities since at some point future time stocks prices and their ongoing real values will merge together.
PARABOLIC DRUGS LTD is considered to be number one stock in beta category among related companies. It is considered to be number one stock in price to sales category among related companies fabricating about  0.02  of Price to Sales per Beta. The ratio of Beta to Price to Sales for PARABOLIC DRUGS LTD is roughly  45.20 
Follow Benchmarks with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker
Check out Your Equity Center. Please also try Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Company logos by clearbit